OMEGA THERAPEUTICS INC (OMGA) Stock Income Statement
NASDAQ:OMGA - US68217N1054 - Common Stock
0.1426 USD
-0.02 (-10.82%)
0.11 USD
-0.03 (-22.86%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.10M | 3.09M | 2.07M | 0.00 | 0.00 | |||
| Operating Expenses | 82.25M | 103.36M | 104.84M | 66.18M | 28.65M | |||
| Research and Development | 56.88M | 65.87M | 76.10M | 47.87M | 21.06M | |||
| Selling, General, and Administrative Expenses | 25.37M | 37.49M | 28.74M | 18.31M | 7.58M | |||
| Operating Income | -74.15M | -100.26M | -102.77M | -66.18M | -28.65M | |||
| Interest Income/Expense | 1.13M | 2.81M | 220.00K | -910.00K | -780.00K | |||
| Other Income/Expense | -73.00K | 23.00K | -160.00K | -1.19M | -30.00K | |||
| Income Before Taxes | -73.09M | -97.43M | -102.70M | -68.28M | -29.45M | |||
| Net Income | -73.09M | -97.43M | -102.70M | -68.28M | -29.45M | |||
| EBITDA | -72.41M | -98.69M | -101.21M | -64.79M | -27.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.33 | -1.80 | -2.14 | -3.05 | -0.63 | |||
| Non GAAP EPS | -1.33 | -1.81 | -2.14 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -902.93% | -3148.93% | -4961.35% | N/A | N/A | |||
| Operating Profit Margin | -916.00% | -3240.50% | -4964.73% | N/A | N/A | |||
All data in USD